Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph II Ruxolitinib after Allogeneic Stem Cell Transplantation for Older Patients with AML in First C

Protocol: OSU-17357

Full Title

Phase II Study of Maintenance Ruxolitinib after Allogeneic Stem Cell Transplantation for Older Patients with Acute Myeloid Leukemia (AML) in First Complete Remission (CR1)

Leukemia Acute Myeloid Leukemia